News and Trends 15 Nov 2017
Swiss Biotech Rakes in Biggest Fundraising of 2017 to Regenerate Heart Valves
Xeltis has raised a €45M Series C to boost the development of its pioneering medical device, RestoreX, which helps to replace damaged heart valves. Xeltis, based in Zurich, Switzerland, is…